Why did 4598.T stock fall 28.03% intraday?

The fall appears liquidity-driven: heavy volume (**7,959,000.00**) versus average (**611,757.00**) amplified selling in a thin small-cap biotech. No company press release tied to the move; sector rotation and technical selling likely contributed.

What are key financial metrics for 4598.T stock to monitor?

Watch **EPS -161.19**, **P/B 8.57**, cash per share **JPY 38.16**, current ratio **3.06**, and shares outstanding **11,493,645.00**. These indicate profitability pressure but near-term liquidity.

What price targets does Meyka AI give for 4598.T stock?

Meyka AI's model projects a 1-year level of **JPY 478.97** (implied upside **79.40%**) and a monthly median of **JPY 504.90**. Forecasts are model-based and not guarantees.

How should traders manage risk on 4598.T stock after today’s drop?

Use small position sizes, set stops near **JPY 260.00**, watch ATR **36.97** for range, and wait for confirmation from volume or clinical updates before scaling exposure.

JP Stocks

4598.T drops 28.03% to JPY 267.00 on JPX 15 Jan 2026: what investors should watch

ByHuzaifa Zahoor January 15, 2026January 15, 2026

The 4598.T stock plunged 28.03% intraday to JPY 267.00 on the JPX as heavy selling pushed volume to 7,959,000.00 shares on 15 Jan 2026. Traders hit the sell button after the market opened at JPY 283.00, amplifying a year-to-date decline of 51.01%. This intraday move stands out against the Healthcare sector’s modest gains and follows thin average liquidity and stretched technicals. We break down drivers, key ratios, Meyka AI grading, and a model forecast to frame near-term trade ideas and risk points